Performance Data to be Presented on New iGenomX™ Single Molecule Assembly Application and the Faster and Automated Analysis Features of the RainDrop® Digital PCR System BILLERICA, Mass. and VANCOUVER, Canada — October 19, 2016 — RainDance Technologies, Inc., a genomics tools company s
Respected Board Member to Head Launch of New Products Incorporating Proprietary Droplet Technology in Liquid Biopsy, Genome Phasing and Single Cell Analysis BILLERICA, Mass. — June 29, 2016 — RainDance Technologies, Inc., a genomics company providing leading-edge digital droplet techn
Next Gen Dx Summit Booth #28 August 23-26, 2016 Washington, DC www.nextgenerationdx.com Circulating Tumor Cell Program: Wed., August 24th at 12:50pm (Lunch Provided) Sensitive Assays to Detect Mutant ESR1 in Plasma Circulating Tumor DNA from Breast Cancer Patient Samples
Abstract The BCR-ABL1 fusion gene sequence is used to help diagnose and monitor treatment and recurrence for chronic myelogenous leukemia (CML). In fact, between 90-95% of diagnosed CML cases are BCR-ABL1-positive. While reverse transcription quantitative PCR (RT-qPCR) is the gold sta
Abstract Minimal residual disease (MRD) in acute myelogenous leukemia (AML) is emerging as an independent risk factor for disease relapse and has significant potential to guide therapeutic decisions. However, current methods for detecting gene mutation-based MRD are limited by a lack
RainDance Technologies prides itself on its continued innovation and ability to deliver Digital Droplet-based solutions that fundamentally enhance the way researchers and scientists study cell-based and cell-free biomarkers in cancer, infectious disease and inherited disorders. We are
The HudsonAlpha Institute for Biotechnology has been named the latest RainDance Center of Excellence and is now a premier reference site and service provider for RainDance products. HudsonAlpha is a nonprofit research institute committed to improving human health and the quality of li
RainDance Technologies® is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside Boston, Massachusetts, the company supports customers using RainDrop® Digital PCR, as well as the ThunderStorm® and ThunderBolts™ Next-Generation Sequencing Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. Both technology platforms have been recognized by The Scientist as Top 10 Innovations with the RainDrop System winning the award in 2014 and the ThunderStorm System winning the award in 2011.